You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mutations in exon 13 of the USH2A gene

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

Active, not recruiting
  • Retinitis Pigmentosa
  • +7 more
  • Dallas, Texas
  • +2 more
Apr 21, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

Completed
  • Retinitis Pigmentosa
  • +7 more
  • QR-421a
  • Sham-procedure (dose cohort 1&2 only)
  • Boston, Massachusetts
  • +6 more
Apr 19, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

Recruiting
  • Retinitis Pigmentosa
  • +7 more
  • San Diego, California
  • +14 more
Jul 29, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

Terminated
Has Results
  • Retinitis Pigmentosa
  • Usher Syndrome Type 2
  • RNA antisense oligonucleotide for intravitreal injection
  • Boston, Massachusetts
  • +6 more
Dec 12, 2022

NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

Suspended
  • NSCLC
  • Winter Haven, Florida
    Bond Clinic, P.A.
Jan 27, 2023

Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Not yet recruiting
  • Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
  • +2 more
    • (no location specified)
    Aug 25, 2023

    Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

    Recruiting
    • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
    • Canton, Ohio
      Gabrail Cancer and Research Center
    Jul 21, 2023

    Duchenne Muscular Dystrophy, Exon 44 Trial in San Antonio (AOC 1044, Placebo)

    Recruiting
    • Duchenne Muscular Dystrophy
    • Exon 44
    • AOC 1044
    • Placebo
    • San Antonio, Texas
      Worldwide Clinical Trials (Part A only)
    Jan 2, 2023

    Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) Trial (DB-OTO)

    Not yet recruiting
    • Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
    • DB-OTO
    • (no location specified)
    Mar 28, 2023

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Jul 17, 2022

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

    Recruiting
    • EGFR Exon 20 Mutation
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Amyotrophic Lateral Sclerosis Trial (AMT-162)

    Not yet recruiting
    • Amyotrophic Lateral Sclerosis
    • (no location specified)
    Oct 20, 2023

    Sensorineural Hearing Loss, Bilateral Trial in Philadelphia (AAVAnc80-hOTOF via Akouos Delivery Device)

    Recruiting
    • Sensorineural Hearing Loss, Bilateral
    • AAVAnc80-hOTOF via Akouos Delivery Device
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Apr 18, 2023

    Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NFS-02 Injection
    • (no location specified)
    Apr 6, 2023

    Trial

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NR082 Injection
    • Injection needle
    • (no location specified)
    Jan 30, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 7, 2023

    Non Small Cell Lung Cancer, EGFR Exon 20 Mutation Trial in Worldwide (CLN-081)

    Recruiting
    • Non Small Cell Lung Cancer
    • EGFR Exon 20 Mutation
    • Duarte, California
    • +18 more
    Nov 11, 2022

    Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)

    Not yet recruiting
    • Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
    • ARTEGENE drug product
    • Paris, France
      Department of Pediatric Immunology, Hematology and Rheumatology
    Sep 26, 2022

    NSCLC, Stage IV, NSCLC Stage IIIB, NSCLC, Stage IIIC Trial in Canada, Hong Kong, United States (tarloxotinib bromide)

    Terminated
    • NSCLC, Stage IV
    • +7 more
    • tarloxotinib bromide
    • Irvine, California
    • +13 more
    Nov 11, 2021

    Methylmalonic Acidemia Trial in United States (hLB-001)

    Recruiting
    • Methylmalonic Acidemia
    • hLB-001
    • Atlanta, Georgia
    • +3 more
    Aug 16, 2022

    Retinitis Pigmentosa Trial in Nantes (AAV2/5-hPDE6B)

    Active, not recruiting
    • Retinitis Pigmentosa
    • AAV2/5-hPDE6B
    • Nantes, France
      Clinique Ophtalmologique, CHU de Nantes
    Feb 28, 2022

    Germline Mutations Associated With Hereditary Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • Pancreatic Adenocarcinoma
    • Invitae Multi-Cancer Panel ®
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Mar 22, 2022

    Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

    Recruiting
    • Frontotemporal Dementia
    • +3 more
    • Intrathalamic AAV.PGRN administration
    • Intrathalamic AVB-101
    • Katowice, Poland
    • +3 more
    Oct 6, 2023

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023